The move reflects a changing business in which traditional food magazines, and a Manhattan address, are less important.
diana s. chang, inc.
125 jericho turnpike, ste. 404
jericho, new york, 11753-1049
NYS Entity Status
NYS Filing Date
APRIL 28, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2014 - DIANA S. CHANG, INC.
AROUND THE WEB
- Food & Wine Magazine Will Leave New York for Alabama
By STEPHANIE STROM - Friday Jun 23, 2017
- Diana Taurasi Breaks W.N.B.A. Scoring Record
By THE ASSOCIATED PRESS - Sunday Jun 18, 2017
With a layup late in the first half of Sunday’s game between her Phoenix Mercury and the Los Angeles Sparks, Taurasi passed Tina Thompson’s record of 7,488 points in a career.
- The Decline of the Baronial C.E.O.
By NELSON D. SCHWARTZ - Saturday Jun 17, 2017
Corporate giants once had all-powerful chiefs with domains to match. But activist investors and technological change are remaking the executive suite.
- Tech Fix: What You Need to Know About the New Uber
By BRIAN X. CHEN - Wednesday Jun 21, 2017
The company has been dogged by scandal for months. One response: changes to its all-important app.
- London, Megyn Kelly, Diana Taurasi: Your Monday Briefing
By CHRIS STANFORD - Monday Jun 19, 2017
Here’s what you need to know to start your day.
- Tenement Museum in New York Names Its New President
By JOSHUA BARONE - Wednesday Jun 14, 2017
Kevin Jennings, a former nonprofit leader and Obama official, plans to expand the museum’s reach through virtual and augmented reality.
- Emil Michael Leaves Uber
By MIKE ISAAC - Monday Jun 12, 2017
The departure of Mr. Michael, a senior vice president, comes after a series of scandals at the company led to an inquiry that recommended his exit.
- “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
By Ben Fidler - Wednesday Jun 7, 2017
Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]